Potential targets may be some genes important for tumor cells or for TME, such as, for example EGF, platelet-derived growth factor (PDGF), basic fibroblast growth factor (bFGF), transforming growth factor beta (TGF-β), TGF-α, and VEGF [82]. This evidence concerns the gene FGF2 and neoplasm.